Identification of Luminal Subtypes of Breast Carcinoma Using Surrogate Immunohistochemical Markers and Ascertaining Their Prognostic Relevance-Reference-Cited by-同舟云学术

Identification of Luminal Subtypes of Breast Carcinoma Using Surrogate Immunohistochemical Markers and Ascertaining Their Prognostic Relevance

Published:2020-10 Issue:5 Volume:20 Page:382-389
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Sali Akash P.^ORCID,Sharma Nishtha,Verma Anuj,Beke Amruta^ORCID,Shet Tanuja,Patil Asawari,Pai Trupti,Nair Nita^ORCID,Parmar Vani,Gupta Sudeep,Hawaldar Rohini,Desai Sangeeta B.

Funder

Tata Memorial Centre

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?;Colozza;Ann Oncol,2005

2. MIB-1 labelling index is an independent prognostic marker in primary breast cancer;Jansen;Br J Cancer,1998

3. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sorlie;Proc Natl Acad Sci U S A,2001

4. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers;Bastien;BMC Med Genomics,2012

5. Comprehensive molecular portraits of human breast tumours;Koboldt;Nature,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low progesterone receptor levels in high-grade DCIS correlate with HER2 upregulation and the presence of invasive components;Frontiers in Oncology;2024-06-26

2. A Clinicopathological Analysis of Molecular Subtypes of Breast Cancer using Immunohistochemical Surrogates: A 6-Year Institutional Experience from a Tertiary Cancer Center in North India;South Asian Journal of Cancer;2023-03-09

3. The Evolution of Ki-67 and Breast Carcinoma: Past Observations, Present Directions, and Future Considerations;Cancers;2023-01-28

4. Molecular subtypes as a prognostic breast cancer factor in women users of the São Paulo public health system, Brazil;Revista Brasileira de Epidemiologia;2023

5. Immunohistochemical Markers as a Surrogate Method for Differentiation of Luminal Subtypes of Breast Cancer and Their Prognostic Significance;Clinical Breast Cancer;2021-02